Melissa Crosby, MD
Plastic Surgery · Sugar Land, TXNPI 1386744688
Payments from drug & device makers
Across 148 payments — averaging $31.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mentor Worldwide LLC$1K
- Galderma Laboratories, L.p.$711
- Sientra, Inc.$650
- AbbVie$538
- Integra Lifesciences Corporation$268
- TELA Bio, Inc.$254
- plus $1K from 26 others
What the payments were for
- Speaking & faculty fees$45010%
- Travel & lodging$190%
- Food & beverage$4,13290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mentor Worldwide LLC | 35 | $1,031 |
| Galderma Laboratories, L.p. | 12 | $711 |
| Sientra, Inc. | 12 | $650 |
| AbbVie(2 entities) | 16 | $538 |
| Integra Lifesciences Corporation | 14 | $268 |
| TELA Bio, Inc. | 14 | $254 |
| Tepha Inc | 2 | $181 |
| Bard Peripheral Vascular, Inc. | 4 | $148 |
| Smith+Nephew | 6 | $96 |
| Wound Management Technologies, Inc | 1 | $71 |
| Axogen | 3 | $65 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $48 |
| Baxter Healthcare | 2 | $47 |
| Acera Surgical, Inc. | 2 | $47 |
| Kerecis Limited | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $42 |
| Aroa Biosurgery Incorporated | 1 | $41 |
| Motiva USA, LLC | 1 | $37 |
| Merz North America, Inc. | 1 | $29 |
| TEI Biosciences Inc | 2 | $29 |
| Amniox Medical, Inc. | 2 | $27 |
| Convatec Inc. | 2 | $25 |
| Dilon Technologies, Inc. | 1 | $24 |
| Coopersurgical, Inc. | 1 | $23 |
| Medtronic | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Biotissue Holdings Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Avanos Medical | 1 | $16 |
| Somavac Medical Solutions, Inc. | 1 | $15 |
| Innovation Technologies Inc | 1 | $12 |
| Trevena, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,601 in reported general payments places this provider in the 60th percentile of 337 plastic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 21 | $848 |
| Mupirocin | 63 | $504 |
| Ondansetron OdtOndansetron | 36 | $271 |
| Levofloxacin | 39 | $241 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $104 |
| Doxycycline Hyclate | 13 | $101 |
| Cephalexin | 14 | $97 |
| Gabapentin | 23 | $64 |
| Tramadol Hcl | 18 | $33 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Sugar Land
- Peter ChangSugar Land$50K
- Rodney RohrichDallas$1.7M
- Younghoon ChoHouston$1.3M
- David AdelmanHouston$405K
- Warren EllsworthHouston$359K
- Regina FearmontiSan Antonio$340K
- Anthony EchoHouston$322K
- Camille CashHouston$227K
- Alexander MericliHouston$188K
- Robert YarishHouston$180K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.